Background: One in every five women suffering from cervical cancer belongs to India. Objectives: In this study, an attempt has been made to screen for cervical cancer in all sexually active females attending Gynaecology Out Patient Department (OPD), segregate operable and inoperable cases, study varying operative management of diagnosed cases of cervical cancer, and study the outcome and complications of the same. Materials and Methods: This was a prospective study carried out in the Department of Obstetrics and Gynaecology in a tertiary care referral hospital in Mumbai amidst the largest urban slum in Asia, Dharavi from January 2011 to December 2016. A total number of 36,100 patients attended the Gynecology OPD during the study period. Being an observational study, only percentage calculations were used in this study. Results: Incidence of neoplasia in this cohort by Pap smear cytology was 0.48%, thus proving the sensitivity of Pap smear to be 84.57%. Most of patients with cervical cancer belonged to the age group 30-39 years (35.9%), lower socioeconomic class (78.18%), and were multiparous (66.36%). Most common presenting complaint was abnormal vaginal discharge (including bleeding) occurring in 87%. Most common histopathological type was squamous cell carcinoma (81.81%). Total abdominal hysterectomy was done in 12 patients (Stage 1a1), Type 2 hysterectomy with pelvic lymph node dissection was done in 16 patients (Stage 1a2, Stage 1b1), and Type 3 hysterectomy with pelvic lymph node dissection was done in 15 patients (Stage 1b2, Stage 2a). Conclusion: Women continue to be afflicted by a disease that is potentially preventable and treatable when detected early. Those who are lost to screening or who do not receive screening at all are most susceptible to the development of cervical cancer.
Cite this article
An observational study of screening, diagnosis, and management of operable cases of cervical cancer in a tertiary institute
1 Department of Obstetrics and Gynaecology, Lokmanya Tilak Municipal Medical College, Sion, Mumbai, India
Eur. J. Gynaecol. Oncol. 2019, 40(1), 119–122; https://doi.org/10.12892/ejgo4511.2019
Published: 10 February 2019